Malaria Journal

official impact factor 3.49

Open Access Research

The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia

Jean-Pierre Van Geertruyden1,5*, Erika Van Eijk2, Francisca Yosaatmadja3, Webster Kasongo4, Modest Mulenga4, Umberto D'Alessandro5 and Stephen Rogerson3

Author Affiliations

1 Unit International Health, Epidemiology and Social Medicine, Antwerp University, Belgium

2 Faculty of Earth and Life Sciences, Vrije Universiteit Amsterdam, the Netherlands

3 Department of Medicine, University of Melbourne, Australia

4 Tropical Disease Research Center, Ndola, Zambia

5 Department Parasitology, Institute of Tropical Medicine, Antwerp, Belgium

For all author emails, please log on.

Malaria Journal 2009, 8:258 doi:10.1186/1475-2875-8-258

Published: 18 November 2009

Abstract

Background

HIV-1 infection affects malaria humeral immunity during pregnancy, but data for non-pregnant adults are lacking. This study reports the impact of HIV-1 infection and other variables on the level of malaria humeral immunity in adults with clinical malaria and whether humeral immune suppression was a risk factor for treatment failure.

Methods

Sera of 224 HIV-1 infected and 115 uninfected adults were compared for IgG to merozoite antigens AMA-1 and MSP2 (3D7 and FC27 types) determined by ELISA, and for IgG to the Variant Surface Antigens (VSA) of three different parasite line E8B, A4 and HCD6 determined by flow cytometry.

Results

Compared to HIV-1 uninfected adults, AMA-1 IgG was lower in HIV-1 infected (P = 0.02) and associated with low CD4 count AMA-1 IgG (P = 0.003). Low IgG to all three merozoite antigens was associated with less anemia (P = 0.03). High parasite load was associated with low MSP2 IgG 3D7 and FC27 types (P = 0.02 and P = 0.08). Antibody levels to VSA did not differ between HIV-1 infected and uninfected adults. However, low VSA IgGs were associated with high parasite load (P ≤ 0.002 for each parasite line) and with treatment failure (P ≤ 0.04 for each parasite line).

Conclusion

HIV-1 affects humeral responses to AMA-1, but seems to marginally or not affect humeral responses to other merozoite antigens and VSAs. The latter were important for controlling parasite density and predict treatment outcome.